Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.7.0.1
CONDENSED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 10,870 $ 14,006
Receivables 1,009 3,587
Prepaid expenses and other current assets 433 237
Total current assets 12,312 17,830
Property and equipment, net 762 837
Total assets 13,074 18,667
Current liabilities:    
Accounts payable 1,537 3,015
Accrued clinical trials expenses 189 1,387
Other accrued liabilities 544 455
Total current liabilities 2,270 4,857
Warrant liabilities 197 619
Total Liabilities 2,467 5,476
Commitments and contingencies
Stockholders’ equity:    
Common stock, at amounts paid-in 297,855 297,855
Additional paid-in capital 24,721 24,300
Accumulated deficit (311,969) (308,964)
Total stockholders’ equity 10,607 13,191
Total liabilities and stockholders' equity $ 13,074 $ 18,667